Home › Post-COVID Conditions (Long COVID) › NCT05022446
The Impact of COVID-19 on Pulmonary Procedures
The Impact of COVID-19 on Pulmonary Procedures: A Nationwide Survey
Who can join
All ages · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Pulmonologists that are members of the American Association of Bronchology and Interventional Pulmonology (AABIP) and/or the American College of Chest Physicians (ACCP) * These organizations were chosen because their member databases are composed of pulmonologists in the United States (U.S.) that perform the pulmonary procedures described in this survey. Letters of approval will be obtained from these organizations and provided to the MD Anderson Institutional Review Board (IRB). Once the MD Anderson IRB approves this survey study, the survey will be sent to the relevant subcommittees of these organizations for their electronic dissemination to their membership Exclusion Criteria: None
About the study
This study investigates the changes in practice by pulmonary procedural programs across the United States as they faced the coronavirus pandemic. Information gathered from this study may help guide pulmonary programs on a wider scale and improve their practice. The study may also help researchers understand where they should focus research efforts to better respond to a pandemic in the future.
What is being tested
- Survey Administration (other)
Sponsor: M.D. Anderson Cancer Center · Participants: 250 · Started: Nov 11, 2020
Contact the study team
- Jhankruti F Zaveri, MPH · Phone: (713) 745-2645
Official record on ClinicalTrials.gov — NCT05022446
Locations in the U.S.
| Texas | M D Anderson Cancer Center, Houston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.